Hadassah

Hadassah Cures Mumbai Child of Thalassemia with Cutting-Edge Diagnosis

Thursday, Mar 26 2015

One day, Prof. Ariel Revel, head of the Ovum Donation and Fertility Preservation Program at the Hadassah Medical Center, was contacted by a professor from Mumbai, who had a one-year-old daughter with Thalassemia, an inherited blood disorder that threatened the quality of her life. Thanks to Hadassah’s state-of-the-art multi-stage intervention—including Pre-Implantation Genetic Diagnosis (PGD), In-vitro Fertilization (IVF), and a bone marrow transplant—that little girl is now Thalassemia-free.

Thalassemia, characterized by the abnormal formation of hemoglobin, is particularly found in people of Mediterranean origin and is prevalent in Israel. In Thalassemia major, the abnormality results in improper oxygen transport and the destruction of red blood cells, causing significant complications such as bone deformities and heart disease. In addition, sufferers often need blood transfusions on a regular basis, resulting in iron overload.

If a person is only a carrier of the disorder (having only one recessive gene for it), the result is mild anemia. If both parents carry the recessive gene, 25 percent of their children will be born with Thalassemia major.

A bone marrow transplant can change the composition of the blood and the fate of a child born with Thalassemia major. The bone marrow donor, however, needs to be close in age, race, and ethnicity to the child. In addition, the donor must have matching human leukocyte antigen (HLA), a particular aspect of the blood type. After researching world databases, the father was told his best option was to have another child, who would hopefully be healthy and a compatible donor for the sister.

Thanks to PGD, this medical intervention is possible. Through PGD, physicians can check the embryos to see if the child will be healthy and an HLA match. When an embryo meeting the qualifications is found, it is implanted into the uterus and the pregnancy proceeds as usual. There are only a few countries in the world that perform these diagnostic tests and Israel is one of them, Prof. Revel said. The Mumbai couple chose to come to Hadassah.

Following ovarian stimulation, Prof. Revel and his team removed 19 eggs from the mother and fertilized them. They examined all resulting embryos through PGD and found two that were an HLA match; however, one was thalassemic. The other, fortunately, was heterozygous for the gene, like the parents, and therefore had only Thalassemia minor. The doctors transferred the embryo to the patient's uterus and a normal pregnancy was launched.

Nine months later, a healthy baby boy was born. When he was one year old, his bone marrow was extracted for transplantation into his sister, making her a healthy three-year-old girl.

Prof. Revel was able to visit the family during a recent professional trip to India. “I had the pleasure of seeing for myself the fruits of our endeavors,” he said. “What a great feeling!”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

Tuesday, Jun 12 2018

Hadassah Ophthalmology Department Research Highlighted by JAMA

Thanking the Hadassah Medical Organization’s researchers for their ”excellent submission” to JAMA Ophthalmology regarding a multi-center international study of the variable effectiveness of treatment for neovascular age-related macular degeneration (nAMD), the editors explained that their article was one of just a few from 12 JAMA on-line journals to be highlighted in The JAMA Network Reader this weekend.

READ MORE ›
alt_text

Monday, Jun 11 2018

Ruth Radiano: Passionate New Director of Nursing at Hadassah Hospital Mount Scopus

Translating her passion and professionalism into action, Ruth Radiano, the new Director of Nursing at Hadassah Hospital Mount Scopus, brings a background of 26 years of nursing at Hadassah.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Former NYC Mayor Giuliani Calls Hadassah Hospital a Blessing

Former New York City Mayor Rudy Giuliani and his partner Dr. Maria Ryan, CEO of Cottage Hospital in Woodsville, New Hampshire visited Hadassah Medical Organization in Jerusalem today to get an update on Hadassah’s management of terror events.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Hadassah Researchers Develop Definitive Biomarker for Cardiac Muscle Death and Link it to Death from Sepsis

Hadassah Medical Organization researchers, in collaboration with colleagues at the Hadassah-Hebrew University School of Medicine, have developed a blood test which definitively detects death of cardiac muscle cells following an acute heart attack and in the case of sepsis.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More